[Federal Register Volume 70, Number 60 (Wednesday, March 30, 2005)]
[Notices]
[Page 16290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-6257]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Preventing Maternal and Neonatal Bacterial Infections in 
Developing Settings With a High Prevalence of HIV: Assessment of the 
Disease Burden and Evaluation of an Affordable Intervention in Soweto, 
South Africa; Notice of Intent To Fund Single Eligibility Award

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
intent to fund fiscal year (FY) 2005 funds for a cooperative agreement 
program to conduct a clinical trial to evaluate the efficacy of 
chlorhexidine vaginal wipes during labor at preventing perinatal and 
maternal post-partum sepsis in an African setting with a high 
prevalence of maternal HIV infection. In conjunction with this trial, 
risk factors for serious neonatal and maternal peripartum infections 
will be evaluated, with an emphasis on the impact of maternal HIV 
infection on these outcomes. Prospective maternal and neonatal 
infections surveillance will also be established to characterize the 
burden of disease. The Catalog of Federal Domestic Assistance number 
for this program is 93.283.

B. Eligible Applicant

    Assistance will be provided only to the Respiratory and Meningeal 
Pathogens Unit of the Medical Research Council of South Africa. No 
other applications are solicited.
    The Respiratory and Meningeal Pathogens Unit is the only 
institution that possesses the requisite scientific and technical 
expertise, the infrastructure capacity and experience and collaborative 
relationships necessary to conduct the described research topics and to 
ensure that all aspects of this agreement can be fulfilled. The Unit 
has already been a single eligibility recipient of a cooperative 
agreement for this activity and is midway through completion of this 
activity. This RFA will allow for completion of the activity.

C. Funding

    Approximately $800,000 is available in FY 2005 to fund this award. 
It is expected that the award will begin on or before August 31, 2005, 
and will be made for a 12-month budget period within a project period 
of up to five years. Funding estimates may change.

D. Where To Obtain Additional Information

    For general comments or questions about this announcement, contact: 
Technical Information Management, CDC Procurement and Grants Office, 
2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For program issues, contact: Trudy Messmer, Scientific Review 
Administrator, 1600 Clifton Road, MS C-19, Atlanta, GA 30333, 
Telephone: (404) 639-3770, E-mail: [email protected].

    Dated: March 24, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-6257 Filed 3-29-05; 8:45 am]
BILLING CODE 4163-18-P